AKTX

Akari Therapeutics News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Akari Therapeutics PLC AKTX NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 2.64 04:03:50
Open Price Low Price High Price Close Price Prev Close
2.64
more quote information »

Recent News

Date Time Source Heading
3/09/20216:37IHNWFeaturedCLS Holdings, (OTCQB: CLSH) $1.49 million Net Revenue for Feb Highest in Company History
3/04/202117:23EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/04/202108:41SEEKAkari Therapeutics inks nomacopan deal with U.S. Army in..
3/04/202108:30GLOBEAkari Therapeutics Announces a Cooperative Research and..
2/25/202116:32EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/25/202109:07GLOBEAkari Therapeutics Presents New Preclinical Data..
2/02/202106:00EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/01/202109:29GLOBEAkari Therapeutics Adds Histamine Inhibitor Votucalis to..
1/06/202109:32GLOBEAkari Therapeutics to Participate in Two January Virtual..
1/04/202106:21EDGARNotice of Effectiveness (effect)
12/23/202017:23EDGARSecurities Registration (foreign Private Issuer) (f-3)
12/11/202016:20EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/11/202016:20EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/11/202009:00GLOBEAkari Therapeutics Reports Third Quarter 2020 Financial..
12/11/202008:55GLOBEAkari Therapeutics Announces New Clinical Data that Show..
12/09/202016:16EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/03/202016:38EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/03/202010:00GLOBEAkari Therapeutics Announces Publication in American Journal..
11/16/202009:41EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/27/202009:00GLOBEAkari Therapeutics to Present Phase II Data from Bullous..
10/06/202009:29EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/06/202008:30GLOBEAkari Therapeutics Announces Further Clinical Trial Progress..
10/01/202009:30EDGARReport of Foreign Issuer (6-k)
10/01/202009:00GLOBEAkari Therapeutics Announces Successful Scientific Advice..
9/29/202009:29GLOBEAkari Therapeutics to Present Its Phase III Plans at the..
9/21/202015:28EDGARNotice of Effectiveness (effect)
9/16/202006:02EDGARPost-effective Amendment to Registration Statement (pos Am)
9/14/202006:01EDGARPost-effective Amendment to Registration Statement (pos Am)
9/14/202006:01EDGARPost-effective Amendment to Registration Statement (pos Am)
9/10/202008:00GLOBEAkari Therapeutics to Participate in Two September Virtual..
9/01/202010:06EDGARReport of Foreign Issuer (6-k)
9/01/202008:30GLOBEAkari Therapeutics Reports Second Quarter 2020 Financial..
8/31/202008:07EDGARReport of Foreign Issuer (6-k)
8/31/202007:00GLOBEAkari Therapeutics Announces International Clinical..
8/12/202008:23GLOBEAkari Therapeutics Announces Successful End-of-Phase II..
8/11/202016:16EDGARAmended Statement of Ownership (sc 13g/a)
7/28/202016:19EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
7/28/202006:07EDGARNotice of Effectiveness (effect)
7/17/202016:27EDGARSecurities Registration (foreign Private Issuer) (f-1)
7/01/202009:23EDGARReport of Foreign Issuer (6-k)
7/01/202009:16GLOBEAkari Therapeutics Enters into a Securities Purchase..
7/01/202009:15GLOBEAkari Therapeutics Announces Appointment of Chief Financial..
6/01/202008:34EDGARReport of Foreign Issuer (6-k)
5/29/202007:31EDGARReport of Foreign Issuer (6-k)
5/29/202007:00GLOBEAkari Therapeutics Reports First Quarter 2020 Financial..
5/21/202016:18EDGARReport of Foreign Issuer (6-k)
5/21/202011:32GLOBEAkari Therapeutics Receives Positive EMA Opinion on Orphan..
5/12/202006:00EDGARNotice of Effectiveness (effect)
5/01/202008:33EDGARReport of Foreign Issuer (6-k)
5/01/202007:00GLOBEAkari Therapeutics Announces Positive Topline Results from..
4/27/202016:15EDGARPost-effective Amendment to Registration Statement (pos Am)
See more news about this stock »


Your Recent History
NASDAQ
AKTX
Akari Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.